These results further support the current consensus that CD44-positive cells represent the chemo-resistant phenotype.19,21,22,27–29 On-going studies using an in-vivo recurrence model of ovarian cancer also showed that tumors initially respond to chemotherapy and shrink considerably. Here, CD44 is linked to ovarian carcinoma.